Score Overview
Amneal Pharmaceuticals, Inc. Class A Common Stock fundamental performance
Between 2020 and 2025, revenue grew from $ 1.99B to $ 3.01B and net income declined from $ 91M to $ 72M. Revenue increased in every one of those 5 years; net income in 3.
Across Amneal Pharmaceuticals, Inc. Class A Common Stock's full reported history, from 2014 to 2025, revenue grew from $ 785M to $ 3.01B and net income declined from $ 176M to $ 72M. Revenue increased in 92% of the years measured; net income in 42%.
Amneal Pharmaceuticals, Inc. Class A Common Stock currently holds a 5-year HDB Score of 7.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 17.66 | — |
1 Year2025-08-12 | $ 9.02 | 95.79% |
5 Years2021-08-12 | $ 5.07 | 248.32% |
10 Years2016-08-12 | $ 21.72 | -18.69% |
All Time2009-01-15 | $ 4.75 | 271.79% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2009-01-15 |
|---|---|---|---|---|---|
| Price | $ 17.66 | $ 9.02 | $ 5.07 | $ 21.72 | $ 4.75 |
| Return | — | 95.79% | 248.32% | -18.69% | 271.79% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3.11B | $ 157M | $ 127M |
| 2025 | $ 3.01B | $ 72M | $ 310M |
| 2024 | $ 2.79B | -$ 116M | $ 112M |
| 2023 | $ 2.39B | -$ 83M | $ 93M |
| 2022 | $ 2.21B | -$ 129M | $ 27M |
| 2021 | $ 2.09B | $ 10M | $ 247M |
| 2020 | $ 1.99B | $ 91M | $ 343M |
| 2019 | $ 1.62B | -$ 361M | $ 152M |
| 2018 | $ 1.66B | -$ 169M | $ 213M |
| 2017 | $ 1.03B | $ 167M | $ 74M |
| 2016 | $ 1.01B | $ 207M | $ 31M |
| 2015 | $ 866M | $ 169M | $ 66M |
| 2014 | $ 785M | $ 176M |
Explore beyond AMRX
You're looking at Amneal Pharmaceuticals, Inc. Class A Common Stock. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
